HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fulvio Baggi Selected Research

Neoplasms (Cancer)

1/2012An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma.
8/2009Risk factors for tumor occurrence in patients with myasthenia gravis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fulvio Baggi Research Topics

Disease

21Myasthenia Gravis
01/2023 - 08/2003
9Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis)
01/2019 - 09/2003
4Multiple Sclerosis
02/2022 - 04/2004
4Autoimmune Diseases (Autoimmune Disease)
01/2017 - 02/2008
3Thymoma (Thymic Carcinoma)
11/2017 - 07/2005
3Thymus Hyperplasia
08/2009 - 08/2003
2Encephalitis (Encephalitis, Rasmussen)
04/2024 - 10/2002
2Seizures (Absence Seizure)
04/2024 - 10/2002
2Disease Progression
01/2019 - 02/2012
2Inflammation (Inflammations)
12/2016 - 04/2016
2Neoplasms (Cancer)
01/2012 - 08/2009
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
06/2006 - 11/2002
2Fibrosis (Cirrhosis)
06/2006 - 11/2002
1Drug Resistant Epilepsy
04/2024
1Status Epilepticus (Complex Partial Status Epilepticus)
04/2024
1Dysbiosis
11/2022
1Multiple System Atrophy
12/2021
1Parkinson Disease (Parkinson's Disease)
12/2021
1Infections
01/2018
1Experimental Arthritis
01/2017
1Muscle Weakness
01/2017
1Communicable Diseases (Infectious Diseases)
11/2016
1Epstein-Barr Virus Infections
04/2016
1Glioblastoma (Glioblastoma Multiforme)
01/2012
1Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome)
09/2008
1Myositis (Idiopathic Inflammatory Myopathies)
06/2008
1Cardiotoxicity
02/2008
1Encephalomyelitis (Myeloencephalitis)
03/2006
1Neuroinflammatory Diseases
03/2006
1Hyperplasia
07/2005
1Muscular Dystrophies (Muscular Dystrophy)
11/2002
1Generalized Epilepsy
10/2002
1Epilepsy (Aura)
10/2002

Drug/Important Bio-Agent (IBA)

11Cholinergic ReceptorsIBA
01/2023 - 02/2004
8Proteins (Proteins, Gene)FDA Link
11/2017 - 11/2002
7AutoantibodiesIBA
01/2023 - 04/2004
4Immunosuppressive Agents (Immunosuppressants)IBA
02/2022 - 02/2008
4Toll-Like Receptors (Toll-Like Receptor)IBA
01/2018 - 07/2005
4Peptides (Polypeptides)IBA
02/2008 - 10/2002
3Biomarkers (Surrogate Marker)IBA
01/2023 - 06/2022
3Immunoglobulin G (IgG)IBA
01/2023 - 09/2008
3Phosphotransferases (Kinase)IBA
01/2023 - 10/2011
3Messenger RNA (mRNA)IBA
11/2016 - 11/2002
2SynucleinsIBA
11/2022 - 12/2021
2VaccinesIBA
02/2022 - 01/2012
2DNA (Deoxyribonucleic Acid)IBA
11/2017 - 02/2008
2AntigensIBA
01/2017 - 02/2012
2pixantrone (BBR 2778)IBA
05/2013 - 02/2008
2CytokinesIBA
09/2008 - 11/2002
2Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2006 - 11/2002
1Pilocarpine (Ocusert)FDA LinkGeneric
04/2024
1methylazoxymethanolIBA
04/2024
1ConnectinIBA
01/2023
1Complement System Proteins (Complement)IBA
06/2022
1BNT162 VaccineIBA
02/2022
1alpha-SynucleinIBA
12/2021
1Therapeutic UsesIBA
01/2019
1Small Nuclear RNA (snRNA)IBA
11/2017
1Epstein-Barr virus encoded RNA 1IBA
11/2017
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2017
1Interleukin-10 (Interleukin 10)IBA
01/2017
1LipidsIBA
01/2017
1Interleukin-4 (Interleukin 4)IBA
11/2016
1MicroRNAs (MicroRNA)IBA
11/2016
1Antiviral Agents (Antivirals)IBA
04/2016
1Toll-Like Receptor 4IBA
08/2014
1muskIBA
01/2013
1Azathioprine (Imuran)FDA LinkGeneric
01/2013
1thiopurine methyltransferase (thiopurine S-methyltransferase)IBA
01/2013
1Immunoglobulins (Immunoglobulin)IBA
08/2009
1KinesinsIBA
06/2008
1Mitoxantrone (Novantrone)FDA LinkGeneric
02/2008
1Type II DNA Topoisomerases (Topoisomerase II)IBA
02/2008
1DystrophinIBA
06/2006
1Neutralizing AntibodiesIBA
06/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2006
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
03/2006
1ErythropoietinFDA Link
03/2006
1Cholinesterase Inhibitors (Anticholinesterases)IBA
08/2003
1CollagenIBA
11/2002
1Connective Tissue Growth FactorIBA
11/2002
1AntibodiesIBA
10/2002
1N 30IBA
10/2002

Therapy/Procedure

7Therapeutics
06/2022 - 03/2006
4Thymectomy
07/2017 - 08/2003
2Activities of Daily Living (ADL)
01/2023 - 11/2017
1Immunotherapy
01/2012
1Immunomodulation
06/2006